EU clinical trial harmonisation pilot expands scope
This article was originally published in Scrip
Executive Summary
Companies planning to undertake multinational clinical trials in just three or more European Union member states are now eligible to participate in the voluntary harmonisation procedure, the pilot programme initiated by the Heads of Medicines Agencies Clinical Trials Facilitation Group that offers co-ordinated and simultaneous review of clinical trial applications.